NASDAQ:GENE Genetic Technologies (GENE) Stock Price, News & Analysis → The Next Nvidia? (From InvestorPlace) (Ad) Free GENE Stock Alerts $2.25 +0.03 (+1.35%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$2.23▼$2.3750-Day Range$1.98▼$3.3652-Week Range$1.80▼$5.90Volume27,393 shsAverage Volume29,068 shsMarket Capitalization$8.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Genetic Technologies alerts: Email Address Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. About Genetic Technologies Stock (NASDAQ:GENE)Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.Read More GENE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GENE Stock News HeadlinesMay 2, 2024 | msn.comGenetic testing helps investigators identify 1989 homicide victim in western MassachusettsApril 30, 2024 | msn.comScientists use cloning technology to revive endangered species: 'Conservationists have worked very hard to bring them back'May 5, 2024 | Stansberry Research (Ad)Gold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).April 30, 2024 | msn.comAI-MARRVEL: A leap forward in diagnosing genetic diseases with over 98% precisionApril 30, 2024 | finance.yahoo.comAppendix 4C & Quarterly Business Update – March 2024April 30, 2024 | globenewswire.comAppendix 4C & Quarterly Business Update – March 2024April 29, 2024 | msn.comResearchers identify genetic cause of rare movement disorderApril 29, 2024 | msn.comScientists' research on RNA editing illuminates possible lifesaving treatments for genetic diseasesMay 5, 2024 | Stansberry Research (Ad)Gold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).April 29, 2024 | finance.yahoo.comBio-E Introduces Pearly White Essence Drink, Enhancing Skin Brightness with Advanced Genetic TechnologyApril 27, 2024 | msn.comMachine learning-powered robot streamlines genetic research processApril 26, 2024 | msn.comExperts develop way to harness CRISPR technology to deal with antimicrobial resistanceApril 26, 2024 | msn.comNew Zealand: How gene technology is changing future of foodApril 26, 2024 | msn.comResearchers Unveil Automated Embryo Injection Technology with Broad ApplicationsApril 26, 2024 | msn.comUnveiling the genetic blueprint of safflowerApril 23, 2024 | msn.comSaving parrots in the illegal wildlife trade with DNA technologyApril 22, 2024 | globenewswire.comGenetic Technologies Announces Closing of US$2 Million Registered Direct OfferingApril 22, 2024 | msn.comNeurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder researchApril 21, 2024 | msn.comSaturday Citations: Irrationality modeled; genetic basis for PTSD; Tasmanian devils still endangeredApril 21, 2024 | msn.comMobile genetic elements can inadvertently suppress bacterial immune systems, research revealsApril 21, 2024 | msn.comHuman Interference Led To The Extinction Of The Dodo Bird By 1690, But Now, A Genetic Engineering Company Is Working To Revive This Bird Species And Return It To Its Original ...April 18, 2024 | morningstar.comADRs End Lower; Genetic Technologies Declines 23%April 18, 2024 | msn.comGenetic Technologies stock tumbles on direct offering pricingApril 18, 2024 | globenewswire.comGenetic Technologies Announces $2 Million Registered Direct OfferingApril 11, 2024 | msn.comBeethoven's DNA Unravels a Musical Mystery: Genetic Paradox UncoveredApril 4, 2024 | washingtonpost.comAuthorities identify remains of man who went missing in Niagara Falls in 1990 and drifted 145 milesApril 4, 2024 | msn.comNew Kaiser genomics lab uses robots for faster, cheaper routine genetic testsSee More Headlines Receive GENE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/05/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GENE CUSIPN/A CIK1166272 Webwww.gtgcorporate.com Phone(138) 412-7000Fax011-61-3-8412-7040Employees60Year Founded1989Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.02 Current Ratio1.67 Quick Ratio1.55 Sales & Book Value Annual Sales$5.85 million Price / Sales1.48 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book1.16Miscellaneous Outstanding Shares3,850,000Free Float3,598,000Market Cap$8.68 million OptionableOptionable Beta1.21 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Simon MorrissChief Executive OfficerMr. Carl S. Stubbings BScChief Commercial OfficerMr. Kevin CamilleriChief Executive Officer of EasyDNAMs. Kathryn J. E. Andrews B.Com. (Age 57)C.P.A., M.A.I.C.D., CFO & Company Secretary Mr. Paul Keith Mathieson Viney B. BusFCI, FCPA, FGIA, ConsultantKey CompetitorsSorrento TherapeuticsNASDAQ:SRNEInhibikase TherapeuticsNYSE:IKTBioCardiaNASDAQ:BCDAChromocell TherapeuticsNYSE:CHROOrganovoNASDAQ:ONVOView All CompetitorsInstitutional OwnershipBNP Paribas Financial MarketsBought 9,100 shares on 5/1/2024Ownership: 0.236%View All Institutional Transactions GENE Stock Analysis - Frequently Asked Questions How have GENE shares performed in 2024? Genetic Technologies' stock was trading at $2.40 on January 1st, 2024. Since then, GENE stock has decreased by 6.1% and is now trading at $2.2546. View the best growth stocks for 2024 here. Are investors shorting Genetic Technologies? Genetic Technologies saw a increase in short interest in April. As of April 15th, there was short interest totaling 15,700 shares, an increase of 36.5% from the March 31st total of 11,500 shares. Based on an average daily volume of 30,000 shares, the short-interest ratio is currently 0.5 days. View Genetic Technologies' Short Interest. When did Genetic Technologies' stock split? Genetic Technologies's stock reverse split on Monday, December 4th 2023. The 1-5 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. What other stocks do shareholders of Genetic Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genetic Technologies investors own include Vascular Biogenics (VBLT), Caladrius Biosciences (CLBS), Inovio Pharmaceuticals (INO), Novavax (NVAX), OPKO Health (OPK), Sangamo Therapeutics (SGMO), Advanced Micro Devices (AMD), Atossa Therapeutics (ATOS), FuelCell Energy (FCEL) and Heat Biologics (HTBX). Who are Genetic Technologies' major shareholders? Genetic Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include BNP Paribas Financial Markets (0.24%). How do I buy shares of Genetic Technologies? Shares of GENE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GENE) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.